BACKGROUND: The replication-competent human immunodeficiency virus (HIV) reservoir is the major barrier to cure. The quantitative viral outgrowth assay (QVOA), the gold-standard method to quantify replication-competent HIV, is resource intensive, which limits its application in large clinical trials. The intact proviral DNA assay (IPDA) requires minimal cell input relative to QVOA and quantifies both defective and intact proviral HIV DNA, the latter potentially serving as a surrogate marker for replication-competent provirus. However, there are limited cross-sectional and longitudinal data on the relationship between IPDA and QVOA measurements. METHODS: QVOA and IPDA measurements were performed on 156 resting CD4 T-cell (rCD4) samples from 83 antiretroviral therapy-suppressed HIV-positive participants. Longitudinal QVOA and IPDA measurements were performed on rCD4 from 29 of these participants. RESULTS: Frequencies of intact, defective, and total proviruses were positively associated with frequencies of replication-competent HIV. Longitudinally, decreases in intact proviral frequencies were strikingly similar to that of replication-competent virus in most participants. In contrast, defective proviral DNA frequencies appeared relatively stable over time in most individuals. CONCLUSIONS: Changes in frequencies of IPDA-derived intact proviral DNA and replication-competent HIV measured by QVOA are similar. IPDA is a promising high-throughput approach to estimate changes in the frequency of the replication-competent reservoir.
BACKGROUND: The replication-competent human immunodeficiency virus (HIV) reservoir is the major barrier to cure. The quantitative viral outgrowth assay (QVOA), the gold-standard method to quantify replication-competent HIV, is resource intensive, which limits its application in large clinical trials. The intact proviral DNA assay (IPDA) requires minimal cell input relative to QVOA and quantifies both defective and intact proviral HIV DNA, the latter potentially serving as a surrogate marker for replication-competent provirus. However, there are limited cross-sectional and longitudinal data on the relationship between IPDA and QVOA measurements. METHODS: QVOA and IPDA measurements were performed on 156 resting CD4 T-cell (rCD4) samples from 83 antiretroviral therapy-suppressed HIV-positive participants. Longitudinal QVOA and IPDA measurements were performed on rCD4 from 29 of these participants. RESULTS: Frequencies of intact, defective, and total proviruses were positively associated with frequencies of replication-competent HIV. Longitudinally, decreases in intact proviral frequencies were strikingly similar to that of replication-competent virus in most participants. In contrast, defective proviral DNA frequencies appeared relatively stable over time in most individuals. CONCLUSIONS: Changes in frequencies of IPDA-derived intact proviral DNA and replication-competent HIV measured by QVOA are similar. IPDA is a promising high-throughput approach to estimate changes in the frequency of the replication-competent reservoir.
Authors: Hiromi Imamichi; Robin L Dewar; Joseph W Adelsberger; Catherine A Rehm; Una O'Doherty; Ellen E Paxinos; Anthony S Fauci; H Clifford Lane Journal: Proc Natl Acad Sci U S A Date: 2016-07-18 Impact factor: 11.205
Authors: Nancie M Archin; Jennifer L Kirchherr; Julia Am Sung; Genevieve Clutton; Katherine Sholtis; Yinyan Xu; Brigitte Allard; Erin Stuelke; Angela D Kashuba; Joann D Kuruc; Joseph Eron; Cynthia L Gay; Nilu Goonetilleke; David M Margolis Journal: J Clin Invest Date: 2017-07-17 Impact factor: 14.808
Authors: Annukka Ar Antar; Katharine M Jenike; Sunyoung Jang; Danielle N Rigau; Daniel B Reeves; Rebecca Hoh; Melissa R Krone; Jeanne C Keruly; Richard D Moore; Joshua T Schiffer; Bareng As Nonyane; Frederick M Hecht; Steven G Deeks; Janet D Siliciano; Ya-Chi Ho; Robert F Siliciano Journal: J Clin Invest Date: 2020-07-01 Impact factor: 14.808
Authors: Michael J Peluso; Peter Bacchetti; Kristen D Ritter; Subul Beg; Jun Lai; Jeffrey N Martin; Peter W Hunt; Timothy J Henrich; Janet D Siliciano; Robert F Siliciano; Gregory M Laird; Steven G Deeks Journal: JCI Insight Date: 2020-02-27
Authors: Rajesh T Gandhi; Joshua C Cyktor; Ronald J Bosch; Hanna Mar; Gregory M Laird; Albine Martin; Ann C Collier; Sharon A Riddler; Bernard J Macatangay; Charles R Rinaldo; Joseph J Eron; Janet D Siliciano; Deborah K McMahon; John W Mellors Journal: J Infect Dis Date: 2021-02-03 Impact factor: 7.759
Authors: Christian Gaebler; Julio C C Lorenzi; Thiago Y Oliveira; Lilian Nogueira; Victor Ramos; Ching-Lan Lu; Joy A Pai; Pilar Mendoza; Mila Jankovic; Marina Caskey; Michel C Nussenzweig Journal: J Exp Med Date: 2019-07-26 Impact factor: 14.307
Authors: N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis Journal: Nature Date: 2012-07-25 Impact factor: 49.962
Authors: Catherine R Cochrane; Thomas A Angelovich; Michael Roche; Melissa J Churchill; Sarah J Byrnes; Emily Waring; Aleks C Guanizo; Gemma S Trollope; Jingling Zhou; Judith Vue; Lachlan Senior; Emma Wanicek; Janna Jamal Eddine; Matthew J Gartner; Trisha A Jenkins; Paul R Gorry; Bruce J Brew; Sharon R Lewin; Jacob D Estes Journal: Ann Neurol Date: 2022-08-09 Impact factor: 11.274
Authors: Ronald J Bosch; Rajesh T Gandhi; Hanna Mar; Joseph J Eron; Joshua C Cyktor; Deborah K McMahon; John W Mellors Journal: J Infect Dis Date: 2022-06-15 Impact factor: 7.759
Authors: Xiaodong Lian; Ce Gao; Xiaoming Sun; Chenyang Jiang; Kevin B Einkauf; Kyra W Seiger; Joshua M Chevalier; Yuko Yuki; Maureen Martin; Rebecca Hoh; Michael J Peluso; Mary Carrington; Ezequiel Ruiz-Mateos; Steven G Deeks; Eric S Rosenberg; Bruce D Walker; Mathias Lichterfeld; Xu G Yu Journal: Sci Transl Med Date: 2021-12-15 Impact factor: 19.319
Authors: Sherazaan D Ismail; Catherine Riou; Sarah B Joseph; Nancie M Archin; David M Margolis; Alan S Perelson; Tyler Cassidy; Melissa-Rose Abrahams; Matthew Moeser; Olivia D Council; Lyle R McKinnon; Farzana Osman; Quarraisha Abdool Karim; Salim S Abdool Karim; Ronald Swanstrom; Carolyn Williamson; Nigel J Garrett; Wendy A Burgers Journal: Clin Infect Dis Date: 2021-10-20 Impact factor: 20.999
Authors: Claire N Levy; Sean M Hughes; Pavitra Roychoudhury; Daniel B Reeves; Chelsea Amstuz; Haiying Zhu; Meei-Li Huang; Yulun Wei; Marta E Bull; Noah A J Cassidy; Jan McClure; Lisa M Frenkel; Mars Stone; Sonia Bakkour; Elizabeth R Wonderlich; Michael P Busch; Steven G Deeks; Joshua T Schiffer; Robert W Coombs; Dara A Lehman; Keith R Jerome; Florian Hladik Journal: Cell Rep Med Date: 2021-04-12
Authors: F Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N Kinloch; Bradley R Jones; Rachel L Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A Brockman; Chanson J Brumme; Jeffrey B Joy; Richard Liang; Bruce D Walker; Zabrina L Brumme Journal: mBio Date: 2021-11-16 Impact factor: 7.867
Authors: Christian Gaebler; Shane D Falcinelli; Elina Stoffel; Jenna Read; Ross Murtagh; Thiago Y Oliveira; Victor Ramos; Julio C C Lorenzi; Jennifer Kirchherr; Katherine S James; Brigitte Allard; Caroline Baker; JoAnn D Kuruc; Marina Caskey; Nancie M Archin; Robert F Siliciano; David M Margolis; Michel C Nussenzweig Journal: J Virol Date: 2021-02-24 Impact factor: 5.103